Literature DB >> 16855858

Magnetic resonance quantitative myocardial perfusion reserve demonstrates improved myocardial blood flow after angiogenic implant therapy.

Prasad Panse1, Chris Klassen, Neeta Panse, Alan Siuciak, Carsten Rickers, Michael Jerosch-Herold, Norbert M Wilke.   

Abstract

PURPOSE: The purpose of this study is to follow myocardial angiogenesis temporally using quantitative magnetic resonance first pass perfusion imaging and compare this with the "gold standard" of radioactive microspheres in a random subset of animals.
MATERIALS AND METHODS: Ameriod constrictors were placed around the left circumflex in 15 pigs to induce an ischemic area. Two groups were randomized to receive either a sham operation or treatment with angiogenic implants inserted into myocardium in the distribution of the left circumflex artery (LCX). These implants are designed to induce myocardial angiogenesis. Magnetic resonance first pass perfusion imaging was performed at baseline and also after treatment with either sham or implant therapy by using first pass perfusion imaging with a TurboFLASH sequence. Absolute myocardial blood flow was derived by applying a quantitative Fermi function model. Radioactive microspheres were also injected into a random subset of animals to measure myocardial blood flow.
RESULTS: Angiogenic implant therapy increased absolute myocardial blood flow in the left circumflex territory relative to baseline and sham treated groups during adenosine infusion. Myocardial blood flows measured with radioactive microspheres was increased significantly in both the LCX and LAD territories during stress. Myocardial Perfusion reserve was also significantly increased in both the LCX and left anterior descending territories relative to baseline. Ejection Fraction during stress with dobutamine infusion increased significantly in the implant therapy group while that in the sham group was not affected.
CONCLUSION: Quantitative MR myocardial first pass perfusion imaging can be used to track the development of angiogenesis as corroborated by radioactive microspheres. Angiogenic implant therapy is a new device based therapy that has potential to protect an ischemic region by accelerating angiogenesis although further research is necessary with this device.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855858     DOI: 10.1007/s10554-006-9105-8

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  9 in total

Review 1.  Magnetic resonance first-pass myocardial perfusion imaging: clinical validation and future applications.

Authors:  N M Wilke; M Jerosch-Herold; A Zenovich; A E Stillman
Journal:  J Magn Reson Imaging       Date:  1999-11       Impact factor: 4.813

Review 2.  Myocardial viability.

Authors:  A E Stillman; N Wilke; M Jerosch-Herold
Journal:  Radiol Clin North Am       Date:  1999-03       Impact factor: 2.303

3.  Effect of intracoronary recombinant human vascular endothelial growth factor on myocardial perfusion: evidence for a dose-dependent effect.

Authors:  R C Hendel; T D Henry; K Rocha-Singh; J M Isner; D J Kereiakes; F J Giordano; M Simons; R O Bonow
Journal:  Circulation       Date:  2000-01-18       Impact factor: 29.690

Review 4.  Angiogenesis by gene therapy: a new horizon for myocardial revascularization?

Authors:  B S Lewis; M Y Flugelman; A Weisz; I Keren-Tal; W Schaper
Journal:  Cardiovasc Res       Date:  1997-09       Impact factor: 10.787

5.  Magnetic resonance quantification of the myocardial perfusion reserve with a Fermi function model for constrained deconvolution.

Authors:  M Jerosch-Herold; N Wilke; A E Stillman
Journal:  Med Phys       Date:  1998-01       Impact factor: 4.071

6.  Cardiac Magnetic Resonance Imaging for the Assessment of Myocardial Angiogenesis.

Authors:  Norbert M. Wilke; Andrey G. Zenovich; Michael Jerosch-Herold; Timothy D. Henry
Journal:  Curr Interv Cardiol Rep       Date:  2001-08

Review 7.  Assessing myocardial perfusion in coronary artery disease with magnetic resonance first-pass imaging.

Authors:  N Wilke; M Jerosch-Herold
Journal:  Cardiol Clin       Date:  1998-05       Impact factor: 2.213

Review 8.  Current and future treatment strategies for refractory angina.

Authors:  Eric H Yang; Gregory W Barsness; Bernard J Gersh; Krishnaswamy Chandrasekaran; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2004-10       Impact factor: 7.616

Review 9.  Novel revascularization therapies--TMLR and growth factor-induced angiogenesis monitored with cardiac MRI.

Authors:  N M Wilke; A Zenovich; O Muehling; M Jerosch-Herold
Journal:  MAGMA       Date:  2000-11       Impact factor: 2.533

  9 in total
  1 in total

1.  Diagnostic accuracy of quantitative cardiac MRI evaluation compared to stress single-photon-emission computed tomography.

Authors:  Hideki Futamatsu; Chris Klassen; Marco Pilla; Norbert Wilke; Dominick J Angiolillo; Stuart Smalheiser; Alan Siuciak; Nobuaki Suzuki; Theodore A Bass; Marco A Costa
Journal:  Int J Cardiovasc Imaging       Date:  2007-09-11       Impact factor: 2.357

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.